naproxen has been researched along with sb 216995 in 1 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (sb 216995) | Trials (sb 216995) | Recent Studies (post-2010) (sb 216995) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 5 | 0 | 0 |
| Protein | Taxonomy | naproxen (IC50) | sb 216995 (IC50) |
|---|---|---|---|
| Chain A, MAP KINASE P38 | Homo sapiens (human) | 0.16 | |
| Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 0.16 | |
| Chain A, PROTEIN (MAP KINASE P38) | Homo sapiens (human) | 0.16 | |
| Chain A, Protein (map Kinase P38) | Homo sapiens (human) | 0.16 | |
| Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 0.16 | |
| Chain A, Extracellular Regulated Kinase 2 | Rattus norvegicus (Norway rat) | 0.16 | |
| Mitogen-activated protein kinase 13 | Homo sapiens (human) | 0.057 | |
| Mitogen-activated protein kinase 12 | Homo sapiens (human) | 0.057 | |
| Mitogen-activated protein kinase 1 | Rattus norvegicus (Norway rat) | 0.16 | |
| Mitogen-activated protein kinase 11 | Homo sapiens (human) | 0.057 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.1188 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, JL; Badger, AM; Boehm, JC; Bradbeer, J; Breton, JJ; Chabot-Fletcher, MC; Gallagher, TF; Garigipati, RS; Griswold, DE; Hillegass, LM; Laydon, JT; Lee, JC; Sheldrake, PL; Smietana, JM; Sorenson, ME | 1 |
1 other study(ies) available for naproxen and sb 216995
| Article | Year |
|---|---|
1-substituted 4-aryl-5-pyridinylimidazoles: a new class of cytokine suppressive drugs with low 5-lipoxygenase and cyclooxygenase inhibitory potency.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arthritis; Bone Density; Cyclooxygenase Inhibitors; Cytokines; Imidazoles; Lipoxygenase Inhibitors; Mice; Mice, Inbred BALB C; Molecular Structure; Morpholines; Prostaglandin-Endoperoxide Synthases; Protein Kinases; Rats; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 1996 |